AIM ImmunoTech Inc - ESG Rating & Company Profile powered by AI
This webpage includes a questions and answers section on AIM ImmunoTech Inc. This Disclosure rating includes 17 United Nations Sustainable Development Goals including: 'Gender Equality', 'Responsible Production & Consumption' and 'Life below Water'. This analysis of AIM ImmunoTech Inc is assembled by All Street Sevva using advanced NLP.
AIM ImmunoTech Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.2; made up of an environmental score of 2.7, social score of 4.8 and governance score of 8.0.
5.2
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 658 | Transchem Ltd | 5.3 | High |
| 658 | Zenith Healthcare Ltd | 5.3 | High |
| 687 | AIM ImmunoTech Inc | 5.2 | High |
| 687 | Cardiol Therapeutics Inc | 5.2 | High |
| 687 | Cell Source Inc | 5.2 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does AIM ImmunoTech Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes AIM ImmunoTech Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes AIM ImmunoTech Inc report the average age of the workforce?
Sign up for free to unlockDoes AIM ImmunoTech Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes AIM ImmunoTech Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes AIM ImmunoTech Inc disclose cybersecurity risks?
Sign up for free to unlockDoes AIM ImmunoTech Inc offer flexible work?
Sign up for free to unlockDoes AIM ImmunoTech Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes AIM ImmunoTech Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes AIM ImmunoTech Inc conduct supply chain audits?
Sign up for free to unlockDoes AIM ImmunoTech Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes AIM ImmunoTech Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes AIM ImmunoTech Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes AIM ImmunoTech Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes AIM ImmunoTech Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes AIM ImmunoTech Inc disclose water use targets?
Sign up for free to unlockDoes AIM ImmunoTech Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid AIM ImmunoTech Inc have a product recall in the last two years?
Sign up for free to unlockDoes AIM ImmunoTech Inc disclose incidents of discrimination?
Sign up for free to unlockDoes AIM ImmunoTech Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas AIM ImmunoTech Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes AIM ImmunoTech Inc disclose parental leave metrics?
Sign up for free to unlockDoes AIM ImmunoTech Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes AIM ImmunoTech Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes AIM ImmunoTech Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes AIM ImmunoTech Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes AIM ImmunoTech Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes AIM ImmunoTech Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs AIM ImmunoTech Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes AIM ImmunoTech Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes AIM ImmunoTech Inc disclose its waste policy?
Sign up for free to unlockDoes AIM ImmunoTech Inc report according to TCFD requirements?
Sign up for free to unlockDoes AIM ImmunoTech Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes AIM ImmunoTech Inc disclose energy use targets?
Sign up for free to unlockDoes AIM ImmunoTech Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes AIM ImmunoTech Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for AIM ImmunoTech Inc
These potential risks are based on the size, segment and geographies of the company.
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, prostate and pancreatic cancer, myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. In addition, the company provides Alferon N Injection, an injectable formulation of natural alpha interferon to treat genital warts, a sexually transmitted disease. It has agreements with UMN Pharma Inc.; Japanese National Institute of Infectious Diseases; Shionogi & Co., Ltd.; Polysciences Inc.; and University of Cagliari Dipartimento di Scienze della Vita e dell'Ambiente. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.